<code id='ABAC27C5A3'></code><style id='ABAC27C5A3'></style>
    • <acronym id='ABAC27C5A3'></acronym>
      <center id='ABAC27C5A3'><center id='ABAC27C5A3'><tfoot id='ABAC27C5A3'></tfoot></center><abbr id='ABAC27C5A3'><dir id='ABAC27C5A3'><tfoot id='ABAC27C5A3'></tfoot><noframes id='ABAC27C5A3'>

    • <optgroup id='ABAC27C5A3'><strike id='ABAC27C5A3'><sup id='ABAC27C5A3'></sup></strike><code id='ABAC27C5A3'></code></optgroup>
        1. <b id='ABAC27C5A3'><label id='ABAC27C5A3'><select id='ABAC27C5A3'><dt id='ABAC27C5A3'><span id='ABAC27C5A3'></span></dt></select></label></b><u id='ABAC27C5A3'></u>
          <i id='ABAC27C5A3'><strike id='ABAC27C5A3'><tt id='ABAC27C5A3'><pre id='ABAC27C5A3'></pre></tt></strike></i>

          focus

          focus

          author:leisure time    Page View:8997
          the shape of a medical note connected by dots and lines — health tech coverage from STAT
          Adobe

          In recent months, the federal government has repeatedly told Medicare Advantage insurers that they cannot use artificial intelligence or algorithms to deny medical services the government routinely covers.

          But in finalizing a rule to that effect, it also stepped into a thicket of questions from insurers about a technology that is especially difficult to pin down: What is AI? Can it be used at all to make decisions about the coverage of older patients? If so, how?

          advertisement

          This week, the federal agency that oversees Medicare sought to boil it all down into a simple directive: Put the circumstances of the individual patient first, and your algorithm second.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more
          With trial win, GSK could get blood cancer drug back on market
          With trial win, GSK could get blood cancer drug back on market

          JUSTINTALLIS/AFPviaGettyImagesLONDON—TheresurrectionofaGSKbloodcancerdrug—whichthecompanywithdrewfro

          read more
          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more

          Antibiotic resistance and the global rise in human conflict

          ApatientwithcrutcheswalkpasttheskeletonofahospitaldestroyedbyaRussianattack.EvgeniyMaloletka/APInrec